About: Lonidamine significantly increases the activity of epirubicin in patients with advanced breast cancer: results from a multicenter prospective randomized trial

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Lonidamine significantly increases the activity of epirubicin in patients with advanced breast cancer: results from a multicenter prospective randomized trial Goto Sponge NotDistinct Permalink

An Entity of Type : wikibase:Item, within Data Space : wikidata.demo.openlinksw.com associated with source document(s)

scientific article published on 01 April 1996

Attributes	Values
rdf:type	Item
description	wetenschappelijk artikel (nl) наукова стаття, опублікована у квітні 1996 (uk) article scientifique publié en 1996 (fr) im April 1996 veröffentlichter wissenschaftlicher Artikel (de) artículu científicu espublizáu n'abril de 1996 (ast) scientific article published on 01 April 1996 (en)
publication date	wds:Q71121091-D9B3F034-D53B-4236-A9EE-FB054ED55AFA
publication date	1996-04-01 00:00:00Z (xsd:dateTime)
language of work or name	wds:Q71121091-F2583F20-D9B2-4243-9BE9-289E58AA04D5
language of work or name	English
author name string	wds:Q71121091-06823F73-A642-40EC-9A61-B4FF83CF26AC wds:Q71121091-1AB63DA0-F000-44AE-9E57-466F62FEC709 wds:Q71121091-28A26E1D-6A02-4AFF-BDE0-68F3487CFDFA wds:Q71121091-2AD06285-1AAE-46D9-B86A-260318624ED6 wds:Q71121091-663172FF-7C39-4B0C-B206-BA796BA79C22 wds:Q71121091-6C34C327-E298-4BD3-A4BB-D3D5CDED30EF wds:Q71121091-960782B9-D0B1-4A4E-BF5E-18160DDE5125 wds:Q71121091-960CCEF6-1268-4495-A7C9-225CC22DCF88 wds:Q71121091-AA44630C-53F0-48D6-B2F4-292622B78B54 wds:Q71121091-B8814DEA-91F1-4F2C-833D-E95CD1B83D41 wds:Q71121091-DFE90E50-D528-45B9-A141-3AB923B7ABD4 wds:Q71121091-EAED0166-F4B6-46F2-B005-81CDE93E2D28 wds:Q71121091-F5A21DE3-65A4-40DD-963A-F167D8F7B8C9 wds:Q71121091-F91DF702-DCA5-4B77-BC9C-C3B6776295FA wds:Q71121091-FA3248BE-3F9C-468A-95C7-C488D7115AFF
author name string	L Dogliotti A Berruti F Deltetto A Farris A Bottini P Alquati P Zola G Moro C Monzeglio M G Sarobba M G Baù T Buniva P Gosso D Perroni M Sussio
rdfs:label	Lonidamine significantly increases the activity of epirubicin in patients with advanced breast cancer: results from a multicenter prospective randomized trial (en) Lonidamine significantly increases the activity of epirubicin in patients with advanced breast cancer: results from a multicenter prospective randomized trial (nl)
skos:prefLabel	Lonidamine significantly increases the activity of epirubicin in patients with advanced breast cancer: results from a multicenter prospective randomized trial (en) Lonidamine significantly increases the activity of epirubicin in patients with advanced breast cancer: results from a multicenter prospective randomized trial (nl)
name	Lonidamine significantly increases the activity of epirubicin in patients with advanced breast cancer: results from a multicenter prospective randomized trial (en) Lonidamine significantly increases the activity of epirubicin in patients with advanced breast cancer: results from a multicenter prospective randomized trial (nl)
title	wds:Q71121091-E3B4CD26-1870-4D87-98F5-E574239DEC5A
title	Lonidamine significantly increases the activity of epirubicin in patients with advanced breast cancer: results from a multicenter prospective randomized trial (en)
page(s)	wds:Q71121091-36E9D416-93FA-4A76-B99E-C74335BC8931
page(s)	1165-1172
instance of	wds:Q71121091-CBBD2400-916D-4CAE-9027-0A27CD58B5CD
instance of	scholarly article
main subject	wds:Q71121091-0F574374-0BB7-4D29-B474-518230648F23
main subject	multicenter clinical trial
PubMed ID	wds:Q71121091-63626E95-A2C0-4402-B891-3CB77ACCBB57
PubMed ID	http://rdf.ncbi.nlm.nih.gov/pubchem/reference/8648371
PubMed ID	8648371
published in	wds:Q71121091-4413F888-F708-461D-A52C-45C64336EEF4
published in	Journal of Clinical Oncology
issue	wds:Q71121091-51281527-65CE-4199-AA04-E422BFC6F66D
volume	wds:Q71121091-C76D9D21-E73E-47D1-AA6A-7968064C2E6C
issue	4
volume	14
DOI	wds:Q71121091-954242E0-1BF9-4D80-873D-A0A1B18EB643
DOI	http://dx.doi.org/10.1200/JCO.1996.14.4.1165
DOI	10.1200/JCO.1996.14.4.1165
is about of	https://www.wikidata.org/wiki/Special:EntityData/Q71121091
is cites work of	Docetaxel and gemcitabine activity in NSCLC cell lines and in primary cultures from human lung cancer Role of apoptotic response in cellular resistance to cytotoxic agents Targeting mitochondria for cancer therapy Modulating effect of lonidamine on response to doxorubicin in metastatic breast cancer patients: Results from a multicenter prospective randomized trial Lonidamine induces apoptosis in drug-resistant cells independently of the p53 gene. Mechanism of antineoplastic activity of lonidamine Single agent epirubicin as first line chemotherapy for metastatic breast cancer patients. In vitro preclinical models for a rational design of chemotherapy combinations in human tumors Lonidamine as a modulator of taxol activity in human ovarian cancer cells: effects on cell cycle and induction of apoptosis. FEC (5-fluorouracil, epidoxorubicin and cyclophosphamide) versus EM (epidoxorubicin and mitomycin-C) with or without lonidamine as first-line treatment for advanced breast cancer. A multicentric randomised study. Final results. Epirubicin. An updated review of its pharmacodynamic and pharmacokinetic properties and therapeutic efficacy in the management of breast cancer The development of lonidamine for benign prostatic hyperplasia and other indications. Weekly epirubicin plus lonidamine in advanced breast carcinoma Relationship between CA 15-3 serum levels and disease extent in predicting overall survival of breast cancer patients with newly diagnosed metastatic disease [Oncology '96] Reviving Lonidamine and 6-Diazo-5-oxo-L-norleucine to Be Used in Combination for Metabolic Cancer Therapy Epirubicin: a review of its efficacy as adjuvant therapy and in the treatment of metastatic disease in breast cancer Matrine Promotes Human Myeloid Leukemia Cells Apoptosis Through Warburg Effect Mediated by Hexokinase 2
is cites work of	wds:Q34133637-20CE5D87-8D97-4B4A-AC20-9F07FAE735D6 wds:Q38920583-582AD0C8-305E-4339-ADBF-C60C97D87560 wds:Q41388354-1C13D9E8-BC93-49BA-8FBB-60F8CE4753A8 wds:Q73315349-60FEF531-E194-46E1-99A3-14572DC18E1D wds:Q34115304-B9B3ABD2-42CE-4B7A-8D79-7B0288CC8F9B wds:Q90680299-93BC1FA9-CD4A-4175-82AB-33520FEF658B wds:Q33795872-8123F2B5-EF54-4B59-816B-F2357F0862AC wds:Q36116173-780614D0-76FB-4649-B672-0BDB1B16C7E1 wds:Q43503224-BC7727EC-286F-4BEB-BF33-73EC76A0AFA0 wds:Q53341833-24B7757A-B5D3-4F8B-BBB5-E82A9E5EE239 wds:Q41735655-4764BB1B-92D0-4776-9BB1-D64D5F1B685D wds:Q41905474-F46167BE-0DAC-43BD-A513-F7378E7AEED2 wds:Q41003446-F8131837-3559-4A00-8AC3-C6D818168666 wds:Q26783189-CC4D12C8-4DA4-4CED-BB8C-83DC357D0F04

Faceted Search & Find service v1.16.117 as of May 05 2024

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3239 as of May 5 2024, on Linux (x86_64-centos_6-linux-gnu), Single-Server Edition (378 GB total memory, 172 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software